Study to assess safety and pharmacokinetics after repeated i.m. administration of 1000 mg Testosterone Undecanoate in hypogonadal male patients
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Open-label study to evaluate safety and pharmacokinetic parameters of total and free testosterone after repeated i.m. administration of 1000 mg testosterone undecanoate (5 injections over 36 weeks) in hypogonadal male patients